| Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020) A Bhimraj, RL Morgan, AH Shumaker, V Lavergne, L Baden, VCC Cheng, ... Clinical infectious diseases 78 (7), e83-e102, 2024 | 1471 | 2024 |
| Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 BD Smith, RL Morgan, GA Beckett, Y Falck-Ytter, D Holtzman, CG Teo, ... Centers for Disease Control and Prevention 61 (RR-4), 1-32, 2012 | 1297 | 2012 |
| Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular CarcinomaA Meta-analysis of Observational Studies RL Morgan, B Baack, BD Smith, A Yartel, M Pitasi, Y Falck-Ytter Annals of internal medicine 158 (5_Part_1), 329-337, 2013 | 1101 | 2013 |
| Identifying the PECO: a framework for formulating good questions to explore the association of environmental and other exposures with health outcomes RL Morgan, P Whaley, KA Thayer, HJ Schünemann Environment international 121 (Pt 1), 1027, 2018 | 842 | 2018 |
| American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer GH Lyman, M Carrier, C Ay, M Di Nisio, LK Hicks, AA Khorana, AD Leavitt, ... Blood Advances 5 (4), 927-974, 2021 | 748 | 2021 |
| GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions N Santesso, C Glenton, P Dahm, P Garner, EA Akl, B Alper, ... Journal of Clinical Epidemiology 119, 126-135, 2020 | 714 | 2020 |
| American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia A Cuker, GM Arepally, BH Chong, DB Cines, A Greinacher, Y Gruel, ... Blood advances 2 (22), 3360-3392, 2018 | 669 | 2018 |
| GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence HJ Schünemann, C Cuello, EA Akl, RA Mustafa, JJ Meerpohl, K Thayer, ... Journal of clinical epidemiology 111, 105-114, 2019 | 644 | 2019 |
| The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine—United States, December 2020 SE Oliver, JW Gargano, M Marin, M Wallace, KG Curran, M Chamberland, ... Morbidity and Mortality Weekly Report 69 (50), 1922, 2020 | 642 | 2020 |
| Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline F Holguin, JC Cardet, KF Chung, S Diver, DS Ferreira, A Fitzpatrick, ... European respiratory journal 55 (1), 2020 | 608 | 2020 |
| GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT HJ Schünemann, W Wiercioch, J Brozek, I Etxeandia-Ikobaltzeta, ... Journal of clinical epidemiology 81, 101-110, 2017 | 599 | 2017 |
| Prediction models for suicide attempts and deaths: a systematic review and simulation BE Belsher, DJ Smolenski, LD Pruitt, NE Bush, EH Beech, DE Workman, ... JAMA psychiatry 76 (6), 642-651, 2019 | 522 | 2019 |
| Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses … AK Rao MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 417 | 2022 |
| The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (January 2021) KE Hanson, AM Caliendo, CA Arias, MK Hayden, JA Englund, MJ Lee, ... Clinical infectious diseases 78 (7), e170-e207, 2024 | 396 | 2024 |
| AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders GL Su, CW Ko, P Bercik, Y Falck-Ytter, S Sultan, AV Weizman, RL Morgan Gastroenterology 159 (2), 697-705, 2020 | 381 | 2020 |
| The advisory committee on immunization practices’ interim recommendation for use of moderna COVID-19 vaccine—United States, December 2020 SE Oliver, JW Gargano, M Marin, M Wallace, KG Curran, M Chamberland, ... Morbidity and Mortality Weekly Report 69 (51-52), 1653, 2021 | 380 | 2021 |
| Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged≥ 65 years—United States, January–March 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 343 | 2021 |
| Hepatitis C virus testing of persons born during 1945–1965: recommendations from the Centers for Disease Control and Prevention BD Smith, RL Morgan, GA Beckett, Y Falck-Ytter, D Holtzman, JW Ward Annals of internal medicine 157 (11), 817-822, 2012 | 327 | 2012 |
| Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among US adults: updated recommendations of the Advisory Committee on Immunization … M Kobayashi MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 314 | 2022 |
| GRADE: Assessing the quality of evidence in environmental and occupational health RL Morgan, KA Thayer, L Bero, N Bruce, Y Falck-Ytter, D Ghersi, G Guyatt, ... Environment international 92, 611-616, 2016 | 296 | 2016 |
Yngve Falck-Ytter, MD AGAFProfessor of Medicine, Case Western Reserve UniversityVerified email at case.edu